Drugmakers Fight FTC Bid For Privileged Antitrust Risk Docs
AbbVie Products LLC and other drugmakers being sued by the Federal Trade Commission and private plaintiffs over patent pay-for-delay settlements for testosterone drug AndroGel have told a Georgia federal court to...To view the full article, register now.
Already a subscriber? Click here to view full article